Swap, don’t sell: Driving value through asset swaps

The Swiss Pharmaceuticals sector produced four USD1 billion+ deals in the first half of 2018. This is not surprising given the efforts by Pharmaceuticals and Life Sciences businesses to push new boundaries and continuously innovate.

Immobilienanleger im Dilemma zwischen Sicherheit und Rendite

Das einst solide Fundament der Immobilienanlage bröckelt. Mangels Anlagealternativen und getrieben von tiefen Zinsen fliesst weiterhin viel Kapital in den Immobilienanlagemarkt. So wird die Ertragssicherung durch kompetentes Asset-Management zum zentralen Erfolgsfaktor für Immobilienanleger.

Brexit and other impacts on the European Transaction Market

Investment in the European real estate market dropped significantly in Q2 2016 compared to the same quarter last year, falling by 26 percent. EUR 107.5 billion was invested in H1 2016, down by 30 percent compared to the same period in 2015.

What is Brexit’s impact on the legal and regulatory side of business?

Despite the unpredictable time frame, companies currently doing business in the UK need to assess Brexit’s impact on their business now in order to develop a strategy to deal with it. How do you assess Brexit’s future impact on the regulatory environment from today’s point of view?

Holpriges Schweizer M&A-Jahr 2015

2015 war ein unruhiges, aber gemessen an den Transaktionsabschlüssen bescheidenes Schweizer M&A-Jahr: Während die Anzahl Transaktionen im Jahresvergleich um 17% zurückging, nahm das Gesamtvolumen der Fusionen und Übernahmen mit Schweizer Beteiligung sogar um 55% ab und betrug 2015 USD 84.9 Milliarden.

Finding your way in a world of change

Each one of us is used to operating in uncertain - even volatile - markets. While we may often wish for more breathing space to think, reflect and plan, we are rarely afforded that opportunity. „The only constant is change“ is the only truly predictable reality. What does vary however, is the speed of change.